This article aims to balance the information from user discussions with reliable medical knowledge, helping readers understand how semaglutide works, why yeast infections might occur, and what to do if they experience them
In the landmark STEP 1 trial, 1,961 participants taking the Wegovy injection (2.4 mg weekly) experienced an average weight loss of approximately 14.9% of their body weight-about 35 lbs from a baseline of 232 lbs-over 68 weeks, compared with just 2.4% in the placebo group
The reality is that Semaglutide, a groundbreaking GLP-1 receptor agonist, has become a cornerstone in the fight against obesity and type 2 diabetes
Its hard to believe that the history of medication-assisted weight loss spans more than a century
Key Takeaways Semaglutide and the ketogenic diet both reduce appetite and regulate blood sugar through complementary mechanisms